Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash
139 tokens/sec
GPT-4o
7 tokens/sec
Gemini 2.5 Pro Pro
46 tokens/sec
o3 Pro
4 tokens/sec
GPT-4.1 Pro
38 tokens/sec
DeepSeek R1 via Azure Pro
28 tokens/sec
2000 character limit reached

Quantifying Hippocampal Shape Asymmetry in Alzheimer's Disease Using Optimal Shape Correspondences (2312.01043v2)

Published 2 Dec 2023 in eess.IV and cs.LG

Abstract: Hippocampal atrophy in Alzheimer's disease (AD) is asymmetric and spatially inhomogeneous. While extensive work has been done on volume and shape analysis of atrophy of the hippocampus in AD, less attention has been given to hippocampal asymmetry specifically. Previous studies of hippocampal asymmetry are limited to global volume or shape measures, which don't localize shape asymmetry at the point level. In this paper, we propose to quantify localized shape asymmetry by optimizing point correspondences between left and right hippocampi within a subject, while simultaneously favoring a compact statistical shape model of the entire sample. To account for related variables that have impact on AD and healthy subject differences, we build linear models with other confounding factors. Our results on the OASIS3 dataset demonstrate that compared to using volumetric information, shape asymmetry reveals fine-grained, localized differences that indicate the hippocampal regions of most significant shape asymmetry in AD patients.

Definition Search Book Streamline Icon: https://streamlinehq.com
References (12)
  1. K.B. Magalingam et al., “Current concepts of neurodegenerative mechanisms in Alzheimer’s disease,” BioMed Research International, 2018.
  2. I. Zawar and J. Kapur, “Does Alzheimer’s disease with mesial temporal lobe epilepsy represent a distinct disease subtype?,” Alzheimer’s & Dementia, vol. 19, no. 6, pp. 2697–2706, 2023.
  3. A. Sarica et al., “MRI asymmetry index of hippocampal subfields increases through the continuum from the mild cognitive impairment to the Alzheimer’s disease,” Frontiers in Neuroscience, vol. 12, pp. 576, 2018.
  4. H. Stefanits et al., “Asymmetry of neurodegenerative disease-related pathologies: a cautionary note,” Acta Neuropathologica, vol. 123, pp. 449–452, 2012.
  5. N.C. Fox et al., “Presymptomatic hippocampal atrophy in Alzheimer’s disease: A longitudinal MRI study,” Brain, vol. 119, no. 6, pp. 2001–2007, 1996.
  6. C. Wachinger et al., “Whole-brain analysis reveals increased neuroanatomical asymmetries in dementia for hippocampus and amygdala,” Brain, vol. 139, no. 12, pp. 3253–3266, 2016.
  7. C. Wachinger et al., “BrainPrint: A discriminative characterization of brain morphology,” NeuroImage, vol. 109, pp. 232–248, 2015.
  8. M. Reuter et al., “Laplace–Beltrami eigenvalues and topological features of eigenfunctions for statistical shape analysis,” Computer-Aided Design, vol. 41, no. 10, pp. 739–755, 2009.
  9. H. Zhang et al., “Spectral mesh processing,” vol. 29, no. 6, pp. 1865–1894, 2010.
  10. J. Cates et al., “Shape modeling and analysis with entropy-based particle systems,” in Information Processing in Medical Imaging, 2007, pp. 333–345.
  11. P.J. LaMontagne et al., “OASIS-3: longitudinal neuroimaging, clinical, and cognitive dataset for normal aging and Alzheimer disease,” MedRxiv, 2019.
  12. J. Cates et al., “Shapeworks: particle-based shape correspondence and visualization software,” in Statistical Shape and Deformation Analysis, pp. 257–298. 2017.

Summary

We haven't generated a summary for this paper yet.

X Twitter Logo Streamline Icon: https://streamlinehq.com